OXALIPLATIN TREATMENT IN HEAVILY PRETREATED PATIENTS (PTS) WITH RECURRENT OVARIAN CARCINOMA (ROC) COULD BE AN EFFECTIVE TREATMENT IN PTS WITH HYPERSENSIBILITY REACTIONS (HSR) TO CARBOPLATIN

被引：0
|
作者：
Manzano, A. [1 ]
Abad, P. [2 ]
Marquina, G. [1 ]
Cabezas, S. [1 ]
Vila, C. [1 ]
Gonzalez, J. [1 ]
Coronado, P. [3 ]
Cordoba, S. [4 ]
Mendez, R. [5 ]
Diaz-Rubio, E. [1 ]
Casado, A. [1 ]
机构：
[1] Hosp Univ Clin San Carlos, Dept Med Oncol, Madrid, Spain
[2] Univ Complutense, Dept Med, E-28040 Madrid, Spain
[3] Hosp Clin San Carlos, Dept Gynecol, Madrid, Spain
[4] Hosp Clin San Carlos, Radiotherapy Oncol Dept, Madrid, Spain
[5] Hosp Clin San Carlos, Dept Radiol, Madrid, Spain
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2015年 / 25卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO-1099
引用
收藏
页码：1431 / 1432
页数：2
相关论文
共 37 条
  • [1] Oxaliplatin and 5-fluorouracil in heavily pretreated patients with ovarian carcinoma: A well tolerated and efficient treatment
    Rosa, D. D.
    Awada, A.
    Cardoso, F.
    Gil, T.
    Lebrun, F.
    Mano, M. S.
    Selleslags, J.
    Piccart, M. J.
    D'Hondt, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Efficacy and safety outcomes in heavily pretreated patients (pts) with relapsed ovarian cancer (ROC) after single-agent trabectedin.
    Salutari, Vanda
    Ferrandina, Gabriella
    Vincenzi, Bruno
    Marinaccio, Marco
    Naglieri, Emanuele
    Loizzi, Vera
    Carpano, Silvia
    Lorusso, Domenica
    De Vincenzo, Rosa Pasqualina
    Grazia, Distefano Maria
    Amadio, Giulia
    Tonini, Giuseppe
    Scambia, Giovanni
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] Weekly single-agent carboplatin in heavily pretreated patients with recurrent ovarian, peritoneal and fallopian tube carcinoma
    Piura, B
    Meirovitz, M
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2005, 26 (04) : 386 - 390
  • [4] Salvage treatment with single-agent capecitabine (C) in patients (pts) with heavily pretreated advanced colorectal cancer (ACRC)
    Ioannidis, GN
    Ardavanis, AS
    Orphanos, GS
    Rigatos, GA
    ANNALS OF ONCOLOGY, 2005, 16 : 286 - 286
  • [5] Analysis of outcomes in patients (pts) with recurrent ovarian clear cell carcinoma (ROCCC): Time to rethink our approach to treatment.
    Tan, David Shao Peng
    Rye, Tzyvia
    Barrie, Colin
    Shaw, Patricia
    Laframboise, Stephane
    Fyles, Anthony W.
    Wang, Lisa
    Gourley, Charlie
    Oza, Amit M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] Tolerability of PLD/Oxaliplatin Regimen in Recurrent Ovarian Cancer Patients With Previous Fragility to Carboplatin/Paclitaxel Treatment
    Dalla Palma, Maurizia
    Lombardi, Giuseppe
    Donach, Martin E.
    Borgato, Lucia
    Zustovich, Fable
    Furini, Lara
    Nicoletto, Maria O.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (03): : 305 - 308
  • [7] Phase II trial of oxaliplatin and 5-FU in patients (pts) with platinum-resistant recurrent (PRR) ovarian carcinoma (OVCA).
    Kerger, Joseph N.
    Lebrun, Fabienne
    Gil, Thierry
    Gombos, Andrea
    Ridoine, Amina
    Bustin, Fanny
    D'hondt, Veronique
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] Safety and Efficacy Outcomes in Heavily and Non-heavily Pretreated Patients With Recurrent Ovarian Cancer (ROC) After Single-agent Trabectedin Treatment - Pooled Analysis of Phase II Trials
    Colombo, N.
    Del Campo, J. M.
    Sehouli, J.
    Sessa, C.
    Bidzinski, M.
    Nieto, A.
    Jiao, J.
    Kurzeder, C.
    Boman, K.
    Gonzalez-Martin, A.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S528 - S529
  • [9] Safety and efficacy outcomes in heavily and non-heavily pretreated patients with recurrent ovarian cancer (ROC) after single-agent trabectedin treatment: pooled analysis of phase II trials
    Kurzeder, C.
    Sehouli, J.
    Brugger, W.
    Zintl, P.
    De la Riba, M., I
    Kreienberg, R.
    ONKOLOGIE, 2011, 34 : 222 - 223
  • [10] Feasibility study of oral cyclophosphamide salvage therapy for the treatment of heavily pretreated patients with recurrent epithelial ovarian cancer
    Watanabe, Yoh
    Etoh, Tomomaro
    Koike, Eiji
    Mizuno, Yoshiaki
    Wang, Wei-Min
    Hoshiai, Hiroshi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2010, 15 (05) : 468 - 471
1234